Filter
1978
Filtered Results: 1978
Text search:
protocolo
de
diagnóstico
Featured
Recommendations
202
New Publications
434
Language
Document type
No document type
955
Guidelines
452
Studies & Reports
305
Manuals
121
Strategic & Response Plan
90
Fact sheets
25
Training Material
15
Situation Updates
9
Brochures
3
Resource Platforms
3
Countries / Regions
Latin America and the Carribbean
75
Global
70
India
66
Senegal
62
Congo, Democratic Republic of
54
Western and Central Europe
53
Brazil
47
Paraguay
40
Africa
37
Burkina Faso
33
Eastern Europe
33
Kenya
32
Colombia
31
Rwanda
31
Benin
29
South Africa
26
Liberia
25
Tanzania
23
Sierra Leone
22
Haiti
22
Nigeria
21
Mozambique
19
Bolivia
19
Guinea
17
Cameroon
16
South–East Asia Region
16
Ecuador
16
Peru
15
Malawi
15
Zambia
14
Madagascar
14
Ukraine
13
West and Central Africa
13
Eastern Europe and Central Asia
13
Argentina
13
Venezuela
12
Uganda
12
Mali
12
Chile
11
Ghana
10
Côte d’Ivoire / Ivory Coast
10
Namibia
10
Philippines
9
East and Southern Africa
9
Russia
9
Togo
8
Syria
8
Central African Republic
8
Ethiopia
8
Angola
8
Nepal
7
El Salvador
7
Zimbabwe
7
Niger
6
Asia
6
Middle East and North Africa
6
North America
6
Bangladesh
6
Myanmar / Burma
6
Lesotho
5
Germany
5
Pakistan
5
Western Pacific Region
4
France
4
Spain
4
Honduras
4
Guatemala
4
China
3
Albania
3
Congo-Brazzaville
3
Afghanistan
3
Burundi
3
Morocco
3
Cambodia
3
Sudan
3
Georgia
3
South Sudan
3
Tajikistan
2
Mexico
2
Canada
2
USA
2
Dominican Republic
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
Uruguay
2
Tunisia
2
Yemen
2
Chad
2
Indonesia
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Turkey
1
Iran
1
Estonia
1
Qatar
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
Maldives
1
Portugal
1
Lebanon
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Botswana
1
Eswatini/ Swaziland
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
800
Clinical Guidelines
245
Public Health
135
Women & Child Health
90
Key Resources
69
Pharmacy & Technologies
46
Capacity Building
22
Toolboxes
COVID-19
238
TB
189
NTDs
125
HIV
116
Mental Health
115
Rapid Response
99
AMR
91
Ebola & Marburg
75
Caregiver
48
NCDs
36
Pharmacy
28
Zika
27
Planetary Health
23
Conflict
22
Disability
18
Refugee
17
Cholera
15
Polio
14
Global Health Education
11
Specific Hazards
9
Natural Hazards
9
Malaria
6
Health Financing Toolbox
3
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepared, according to the first annual report from the Global Preparedness Monitoring Board. The WHO and the World Bank convened the independent group after ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Global Campaign Against Epilepsy “Out of the Shadows”
Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the relationships between HIV disease and maternal morbidity and mortality, integrated and effective resp...
Journal of the International AIDS Society 2016, 19:20926
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
There is a growing interest in the potential contribution the private sector can make towards increasing access to antiretroviral therapy (ART) in low‐ and middle‐income settings. This article describes a public–private partnership ...
The Lancet Global Health 2016 Published Online August 30, 2016
http://dx.doi.org/10.1016/S2214-109X(16)30175-9
International Perspectives and Future Directions
Regional situation analysis, practices, experiences, lessons learned and ways forward.
Background paper 7
The Independent Panel for Pandemic Preparedness and Response
May 2021
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
PLOS Neglected Tropical Diseases 18(4): e0012111. https://doi.org/10.1371/journal.pntd.0012111
Mass population movements have accounted for the emergence of Chagas disease (CD) outside endemic regions,
including the European Union/European Economic Area (EU/EEA). The parasite responsible for causing CD,
Trypanosoma cruzi (T. cruzi), can be transmitted through substances of human origin (SoH...
The main objective of the 2014-15 RDHS was to obtain current information on demographic and health indicators, including family planning; maternal mortality; infant and child mortality; nutrition status of mothers and children; prenatal care, delivery, and postnatal care; childhood diseases; and ped...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta...
